Synapse - Find an Expert

Results (147)

A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC

Meeting Abstract

Rizvi, N.; Pao, W.; Miller, V.; Rusch, V.; Heelan, R.; Ladanyi, M.; Ginex, P.; Tyson, L.; Zakowski, M.; Kris, M.
Lung Cancer (2005)

Fulltext@MSK | Save

Lung adenocarcinomas with mutations in EGFR and KRAS have distinct gene expression profiles

Meeting Abstract

Pham, D.; Sarkaria, I.; Socci, N.; Pao, W.; Zakowski, M.; Miller, V.; Kris, M.; Rusch, V.; Singh, B.
Lung Cancer (2005)

Fulltext@MSK | Save

Impairment of myocardial contractile reserve following pulmonary lobectomy is biventricular and not improved by a video-assisted thoracic surgery (VATS) approach

Meeting Abstract

Park, B.; Markov, N.; Malhotra, J.; Schaefer, U.; Heerdt, P.
Lung Cancer (2005)

Fulltext@MSK | Save

Genetic instability, response to DNA damage, and repair capacity in individuals with multiple primary non-small cell lung cancers

Meeting Abstract

Orlow, I.; Park, B.; Clas, B.; Mujumdar, U.; Dominguez, G.; Bhingradia, H.; Ginex, P.; Kris, M.; Rusch, V.; Begg, C.; more...
Lung Cancer (2005)

Fulltext@MSK | Save

A comparison of the antitumour efficacy of ZD6474 and gefitinib (IresSa (TM)) in patients with NSCLC: Results of a randomized, double-blind phase II study

Meeting Abstract

Natale, R.; Bodkin, D.; Govindan, R.; Sleckman, B.; Rizvi, N.; Capo, A.; Germonpre, P.; Dimery, I.; Webster, A.; Ranson, M.
Lung Cancer (2005)

Fulltext@MSK | Save

Gene expression profiling of malignant mesothelioma for prognostic prediction and identification of potential therapeutic targets and differential diagnostic markers

Meeting Abstract

Lopez-Rios, F.; Chuai, S.; Hussain, S.; Szoke, J.; Gerald, W.; Zakowski, M.; Olshen, A.; Flores, R.; Rusch, V.; Ladanyi, M.
Lung Cancer (2005)

Fulltext@MSK | Save

A multicenter phase 2 trial of neo-adjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM)

Meeting Abstract

Krug, L.; Pass, H.; Rusch, V.; Sugarbaker, D.; Rosenzweig, K.; Friedberg, J.; Bloss, L.; Obasaju, C.; Vogelzang, N.
Lung Cancer (2005)

Fulltext@MSK | Save

Gemcitabine/cisplatin plus bevacizumab or placebo in advanced malignant mesothelioma: A multi-center, double-blind, placebo-controlled, randomized phase III trial

Meeting Abstract

Kindler, H.; Lu, C.; Gandara, D.; Stevenson, J.; Krug, L.; Janne, P.; Gitlitz, B.; Karrison, T.; Stadler, W.; Vokes, E.
Lung Cancer (2005)

Fulltext@MSK | Save

Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER climerization inhibitor, in non-small cell lung cancer (NSCLC) patients after prior chemotherapy